Search

Your search keyword '"Arita, Hideyuki"' showing total 299 results

Search Constraints

Start Over You searched for: Author "Arita, Hideyuki" Remove constraint Author: "Arita, Hideyuki"
299 results on '"Arita, Hideyuki"'

Search Results

4. Neuroradiological, genetic and clinical characteristics of histone H3 K27-mutant diffuse midline gliomas in the Kansai Molecular Diagnosis Network for CNS Tumors (Kansai Network): multicenter retrospective cohort

8. Clinical significance of CDKN2A homozygous deletion in combination with methylated MGMT status for IDH-wildtype glioblastoma.

9. TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.

13. Prediction of MGMT promotor methylation status in glioblastoma by contrast-enhanced T1-weighted intensity image

14. TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

15. 10015-NI-1 PREDICTION OF MGMT PROMOTOR METHYLATION STATUS IN GLIOBLASTOMA BY CONTRAST-ENHANCED T1-WEIGHTED IMAGE

16. Molecular characteristics and clinical outcomes of elderly patients with IDH-wildtype glioblastomas: comparative study of older and younger cases in Kansai Network cohort

17. Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors

18. Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network

19. Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma

20. Supplementary Data from LPA4-Mediated Vascular Network Formation Increases the Efficacy of Anti–PD-1 Therapy against Brain Tumors

21. Data from LPA4-Mediated Vascular Network Formation Increases the Efficacy of Anti–PD-1 Therapy against Brain Tumors

23. WT1 Trio Peptide-Based Cancer Vaccine for Rare Cancers Expressing Shared Target WT1

24. Additional file 1 of Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysis

25. Additional file 3 of Linear accelerator-based stereotactic radiotherapy for brain metastases, including multiple and large lesions, carries a low incidence of acute toxicities: a retrospective analysis

27. Nonbrain metastases seen on magnetic resonance imaging during metastatic brain tumor screening

28. Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas

31. Human chorionic gonadotropin is expressed virtually in all intracranial germ cell tumors

35. DNA methylome analysis suggested the presence of “true” IDH-wildtype lower-grade gliomas

37. Preliminary Report on Endoscopy-assisted Suturectomy for Craniosynostosis

38. MPC-1 DNA methylome analysis suggested the presence of “true” IDH-wildtype lower-grade gliomas

39. Eribulin prolongs survival in an orthotopic xenograft mouse model of malignant meningioma

Catalog

Books, media, physical & digital resources